{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:56Z","timestamp":1790712536546,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173238"],"award-info":[{"award-number":["82173238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112887","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:59:13Z","timestamp":1790175553000},"page":"112887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epitranscriptomic stabilization of PGRMC1 by the METTL3\u2013IGF2BP1 axis promotes ovarian cancer progression"],"prefix":"10.1016","volume":"149","author":[{"given":"Yue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cellsig.2026.112887_bb0005","first-page":"1239","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Can."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112887_bb0010","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian Cancer: a review","volume":"334","author":"Caruso","year":"2025","journal-title":"Jama"},{"key":"10.1016\/j.cellsig.2026.112887_bb0015","article-title":"Ovarian cancer targeted therapy: current landscape and future challenges","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40364-025-00818-7","article-title":"Therapeutic landscape of ovarian cancer: recent advances and emerging therapies","volume":"13","author":"Wang","year":"2025","journal-title":"Biomark. Res."},{"issue":"28","key":"10.1016\/j.cellsig.2026.112887_bb0025","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41388-025-03448-3","article-title":"Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatment","volume":"44","author":"Narayana","year":"2025","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112887_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071525","article-title":"Management of Advanced Ovarian Cancer: current clinical practice and future perspectives","volume":"13","author":"Papageorgiou","year":"2025","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.cellsig.2026.112887_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells14130995","article-title":"Immunotherapy for platinum-resistant ovarian Cancer as a glimmer of Hope","volume":"14","author":"Brancewicz","year":"2025","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112887_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cellsig.2026.112887_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7007-8-88","article-title":"Altered metabolism in cancer","volume":"8","author":"Locasale","year":"2010","journal-title":"BMC Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112887_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061303","article-title":"Metabolic reprogramming in Cancer cells: emerging molecular mechanisms and novel therapeutic approaches","volume":"14","author":"Navarro","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112887_bb0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1742-4658.2012.08479.x","article-title":"Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts","volume":"279","author":"Fabian","year":"2012","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112887_bb0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41389-020-0209-0","article-title":"PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via \u03b15\u03b21 integrin and JNK\/IL-8 signaling","volume":"9","author":"Siu","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.cellsig.2026.112887_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114798","article-title":"Novel association between E3 ubiquitin ligase MARCH8 and glucose transporter Glut1 in intracerebral hemorrhage","volume":"158","author":"Yao","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112887_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101316","article-title":"Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism","volume":"297","author":"McGuire","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.cellsig.2026.112887_bb0075","doi-asserted-by":"crossref","first-page":"24775","DOI":"10.1074\/jbc.M110.134585","article-title":"Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity","volume":"285","author":"Ahmed","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112887_bb0080","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2007-2771","article-title":"Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1","volume":"93","author":"Peluso","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12860-020-00268-z","article-title":"PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease","volume":"21","author":"Thejer","year":"2020","journal-title":"BMC Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0090","article-title":"Progesterone receptor membrane component 1 suppresses the p53 and Wnt\/\u03b2-catenin pathways to promote human pluripotent stem cell self-renewal","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112887_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4236\/alc.2015.43006","article-title":"PGRMC1 elevation in multiple cancers and essential role in stem cell survival","volume":"4","author":"Hampton","year":"2015","journal-title":"Adv. Lung Cancer (Irvine)"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112887_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/GME.0000000000000739","article-title":"Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer","volume":"24","author":"Ruan","year":"2017","journal-title":"Menopause"},{"issue":"2 Pt B","key":"10.1016\/j.cellsig.2026.112887_bb0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.canlet.2014.09.036","article-title":"Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors","volume":"356","author":"Friel","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.117.110510","article-title":"Insulin receptor plasma membrane levels increased by the progesterone receptor membrane component 1","volume":"94","author":"Hampton","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112887_bb0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrm3785","article-title":"The dynamic epitranscriptome: N6-methyladenosine and gene expression control","volume":"15","author":"Meyer","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","article-title":"METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer","volume":"21","author":"Wan","year":"2022","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112887_bb0135","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","article-title":"IGF2BPs as novel m(6)A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment","volume":"11","author":"Duan","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.cellsig.2026.112887_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106700","article-title":"Mechanisms of immune escape in the cancer immune cycle","volume":"86","author":"Tang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112887_bb0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41571-024-00937-4","article-title":"Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach","volume":"21","author":"Ghisoni","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112887_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1328651","article-title":"Targeting the immune microenvironment for ovarian cancer therapy","volume":"14","author":"Blanc-Durand","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112887_bb0155","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","article-title":"Fibroblasts in cancer: unity in heterogeneity","volume":"186","author":"Chhabra","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","article-title":"High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification","volume":"13","author":"Olbrecht","year":"2021","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112887_bb0170","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","article-title":"Heterogeneity and treatment landscape of ovarian carcinoma","volume":"20","author":"Veneziani","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112887_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108326","article-title":"PGRMC1: an enigmatic heme-binding protein","volume":"241","author":"McGuire","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112887_bb0180","first-page":"907","article-title":"Cloning and tissue expression of two putative steroid membrane receptors","volume":"379","author":"Gerdes","year":"1998","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112887_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101068","article-title":"MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1\/EGFR-PI3K\/Akt\/mTOR signaling pathway","volume":"14","author":"Cai","year":"2021","journal-title":"Transl. Oncol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112887_bb0190","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00018-014-1831-9","article-title":"PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma","volume":"72","author":"Lin","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04207-7","article-title":"The METTL3\/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4","volume":"399","author":"Chen","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112887_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.682461","article-title":"PGK1 is a key target for anti-glycolytic therapy of ovarian cancer: based on the comprehensive analysis of glycolysis-related genes","volume":"11","author":"Gou","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112887_bb0205","doi-asserted-by":"crossref","first-page":"8781","DOI":"10.1038\/s41598-021-88251-2","article-title":"Progesterone receptor membrane component 1 reduces cardiac steatosis and lipotoxicity via activation of fatty acid oxidation and mitochondrial respiration","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112887_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70121","article-title":"Targeting progesterone receptor membrane component 1 to improve muscle development and glucose homeostasis","volume":"16","author":"Lee","year":"2025","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112887_bb0215","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41416-020-0992-6","article-title":"Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR\/PI3K\/AKT signalling","volume":"123","author":"Pedroza","year":"2020","journal-title":"Br. J. Cancer"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:36:54Z","timestamp":1790710614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":43,"alternative-id":["S0898656826005462"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112887","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitranscriptomic stabilization of PGRMC1 by the METTL3\u2013IGF2BP1 axis promotes ovarian cancer progression","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112887"}}